Temporal stability of serum concentrations of cytokines and soluble receptors measured across two years in low-risk HIV-seronegative men

Cancer Epidemiology Biomarkers and Prevention

Volumn 22, Issue 11, 2013, Pages 2009-2015

  Epstein, Mara M ^a,b,k,l,m   Breen, Elizabeth Crabb ^c,d   Magpantay, Larry ^c   Detels, Roger ^e   Lepone, Lauren ^f   Penugonda, Sudhir ^g   Bream, Jay H ^h   Jacobson, Lisa Paula ⁱ   Martínez Maza, Otoniel ^c,e,j   Birmann, Brenda M ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d Departments of Psychiatry and Biobehavioral Sciences   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^g NORTHWESTERN UNIVERSITY   (United States)

^h Departments of Molecular Microbiology and Immunology   (United States)

ⁱ JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^j Immunology and Molecular Genetics   (United States)

^k UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^l Division of Geriatric Medicine   (United States)

^m UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A1; BIOLOGICAL MARKER; CD14 ANTIGEN; CXCL13 CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GLYCOPROTEIN GP 130; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; INTERLEUKIN 8; PROTEIN; PROTEIN BAFF; SOLUBLE CD14 ANTIGEN; SOLUBLE GLYCOPROTEIN GP 130; SOLUBLE INTERLEUKIN 2 RECEPTOR ALPHA; SOLUBLE INTERLEUKIN 6 RECEPTOR; SOLUBLE TUMOR NECROSIS FACTOR RECEPTOR 2; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; ARTICLE; BISEXUAL MALE; BLOOD SAMPLING; CONTROLLED STUDY; ETHNICITY; HOMOSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LOW RISK POPULATION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; PROTEIN STABILITY; SEASON; SEROCONVERSION; SEXUAL BEHAVIOR;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; CYTOKINES; HIV INFECTIONS; HIV SERONEGATIVITY; HOMOSEXUALITY, MALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; UNITED STATES; YOUNG ADULT;

EID: 84887302496     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-13-0379     Document Type: Article

References (31)

1. Vendrame E, Martinez-Maza O. Assessment of pre-diagnosis biomarkers of immune activation and inflammation: insights on the etiology of lymphoma. J Proteome Res 2011;10:113-9.
2. Pine SR, Mechanic LE, Enewold L, Chaturvedi AK, Katki HA, Zheng YL, et al. Increased levels of circulating interleukin 6, interleukin 8, Creactive protein, and risk of lung cancer. J Natl Cancer Inst 2011;103: 1112-22.
3. Tsilidis KK, Branchini C, Guallar E, Helzlsouer KJ, Erlinger TP, Platz EA. C-reactive protein and colorectal cancer risk: A systematic review of prospective studies. Int J Cancer 2008;123: 1133-40.
4. Erlinger TP, Platz EA, Rifai N, Helzlsouer KJ. C-reactive protein and the risk of incident colorectal cancer. JAMA 2004;291:585-90.
5. Stark JR, Li H, Kraft P, Kurth T, Giovannucci EL, Stampfer MJ, et al. Circulating prediagnostic interleukin-6 and C-reactive protein and prostate cancer incidence and mortality. Int J Cancer 2009;124: 2683-9.
6. Touvier M, Fezeu L, Ahluwalia N, Julia C, Charnaux N, Sutton A, et al. Association between prediagnostic biomarkers of inflammation and endothelial function and cancer risk: A nested case-control study.AmJ Epidemiol 2013;177:3-13.
7. Najib E, Puranik R, Duflou J, Xia Q, Bao S. Age related inflammatory characteristics of coronary artery disease. Int J Cardiol 2012;154: 65-70.
8. Rabinovitch A, Suarez-Pinzon WL. Cytokines and their roles in pancreatic islet beta-cell destruction and insulin-dependent diabetes mellitus. Biochem Pharmacol 1998;55:1139-49.
9. O'Connor JC, Satpathy A, Hartman ME, Horvath EM, Kelley KW, Dantzer R, et al. IL-1beta-mediated innate immunity is amplified in the db/db mouse model of type 2 diabetes. J Immunol 2005;174: 4991-7.
10. Ho GY, Xue XN, Burk RD, Kaplan RC, Cornell E, Cushman M. Variability of serum levels of tumor necrosis factor-alpha, interleukin 6, and soluble interleukin 6 receptor over 2 years in young women. Cytokine 2005;30:1-6.
11. Lee SA, Kallianpur A, Xiang YB, Wen W, Cai Q, Liu D, et al. Intraindividual variation of plasma adipokine levels and utility of single measurement of these biomarkers in population-based studies. Cancer Epidemiol Biomarkers Prev 2007;16:2464-70.
12. Wong HL, Pfeiffer RM, Fears TR, Vermeulen R, Ji S, Rabkin CS. Reproducibility and correlations of multiplex cytokine levels in asymptomatic persons. Cancer Epidemiol Biomarkers Prev 2008;17:3450-6.
13. Gu Y, Zeleniuch-Jacquotte A, Linkov F, Koenig KL, Liu M, Velikokhatnaya L, et al. Reproducibility of serum cytokines and growth factors. Cytokine 2009;45:44-9.
14. Clendenen TV, Arslan AA, Lokshin AE, Idahl A, Hallmans G, Koenig KL, et al. Temporal reliability of cytokines and growth factors in EDTA plasma. BMC Res Notes 2010;3:302.
15. Hofmann JN, Yu K, Bagni RK, Lan Q, Rothman N, Purdue MP. Intraindividual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial. Cytokine 2011;56:145-8.
16. Navarro SL, Brasky TM, Schwarz Y, Song X, Wang CY, Kristal AR, et al. Reliability of serum biomarkers of inflammation from repeated measures in healthy individuals. Cancer Epidemiol Biomarkers Prev 2012;21:1167-70.
17. Kaslow RA, Ostrow DG, Detels R, Phair JP, Polk BF, Rinaldo CR Jr. The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol 1987;126:310-8.
18. Dudley J, Jin S, Hoover D, Metz S, Thackeray R, Chmiel J. The Multicenter AIDS Cohort Study: retention after 9 1/2 years. Am J Epidemiol 1995;142:323-30.
19. Martinez-Maza O, Detels R, Magpantay L, Phair J, Bream JH, Rinaldo CR, et al. Highly-exposed HIV seronegative persons (HESN) had higher levels of inflammatory and immune activation-associated serum biomarkers than lower risk HIV seroconverters (LRSC) [abstract]. Abstracts of the XIX International AIDS Conference. J Int AIDS Soc 2012;15(Suppl 3). Abstract number WEPDA0102.
20. Kirstein LM, Mellors JW, Rinaldo CR Jr, Margolick JB, Giorgi JV, Phair JP, et al. Effects of anticoagulant, processing delay, and assay method (branched DNA versus reverse transcriptase PCR) on measurement of human immunodeficiency virus type 1 RNA levels in plasma. J Clin Microbiol 1999;37:2428-33.
21. Breen EC, Reynolds SM, Cox C, Jacobson LP, Magpantay L, Mulder CB, et al. Multisite comparison of high-sensitivity multiplex cytokine assays. Clin Vaccine Immunol 2011;18:1229-42.
22. Laird NM, Ware JH. Random-effects models for longitudinal data. Biometrics 1982;38:963-74.
23. McLean RA, Sanders WL, Stroup WW. A unified approach to mixed linear models. Am Stat 1991;45:54-64.
24. Hankinson SE, Manson JE, Spiegelman D, Willett WC, Longcope C, Speizer FE. Reproducibility of plasma hormone levels in postmenopausal women over a 2-3-year period. Cancer Epidemiol Biomarkers Prev 1995;4:649-54.
25. Shrout PE, Fleiss JL. Intraclass correlations: uses in assessing rater reliability. Psychol Bull 1979;86:420-8.
26. Rosner B. Chapter 11: regression and correlation methods. In: Fundamentals of biostatistics, sixth edition. Belmont, CA: Thomson Brooks/Cole; 2006. p. 540-6.
27. Linkov F, Gu Y, Arslan AA, Liu M, Shore RE, Velikokhatnaya L, et al. Reliability of tumor markers, chemokines, and metastasis-related molecules in serum. Eur Cytokine Netw 2009;20:21-6.
28. Kotsopoulos J, Tworoger SS, Campos H, Chung FL, Clevenger CV, Franke AA, et al. Reproducibility of plasma and urine biomarkers among premenopausal and postmenopausal women from the Nurses' Health Studies. Cancer Epidemiol Biomarkers Prev 2010; 19:938-46.
29. Rosner B, Willett WC. Interval estimates for correlation coefficients corrected for within-person variation: implications for study design and hypothesis testing. Am J Epidemiol 1988;127:377-86.
30. Tworoger SS, Eliassen AH, Rosner B, Sluss P, Hankinson SE. Plasma prolactin concentrations and risk of postmenopausal breast cancer. Cancer Res 2004;64:6814-9.
31. Rosner B, Spiegelman D, Willett WC. Correction of logistic regression relative risk estimates and confidence intervals for random withinperson measurement error. Am J Epidemiol 1992;136:1400-13.